Gregory B. Sivolapenko

Dr. Gregory Sivolapenko qualified in Pharmacy from the University of Athens in 1984 and obtained his Ph.D. in Medicine (Immunology and Clinical Oncology) from the University of London, UK, in 1990. During the period 1985-1990 he had worked as Research Fellow at the Hammersmith Hospital in London and at the Imperial Cancer Research Fund (UK). Over the last thirty years, Dr. Sivolapenko has researched into cancer in the UK and Greece, with particular interest in tumour targeting using monoclonal antibodies and novel antibody-derived molecules. His academic preclinical and clinical research has resulted in a large number of publications at international medical journals and books. In addition, Dr. Sivolapenko has gained international pharmaceutical product development experience focusing in clinical research through his employment, board membership and/or advisory position in pharmaceutical and CRO companies. Since March 2005, Dr. Sivolapenko holds the position of Associate Professor at the School of Pharmacy and Head of the Pharmacokinetics Laboratory, University of Patras, Greece.